Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Immediate Corrective Actions in Case of Deviations – V 2.0

Posted on By

Gel Manufacturing: SOP for Immediate Corrective Actions in Case of Deviations – V 2.0

Standard Operating Procedure for Handling Immediate Corrective Actions During Deviations in Gel Manufacturing


Department Gel Manufacturing
SOP No. SOP/GM/079/2025
Supersedes SOP/GM/079/2022
Page No. Page 1 of 11
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

This Standard Operating Procedure (SOP) provides clear guidance on taking immediate corrective actions during any deviations observed in the gel manufacturing process to ensure product quality and regulatory compliance.

2. Scope

This SOP is applicable to all operational stages of gel manufacturing

— including dispensing, mixing, deaeration, filling, and in-process checks — where deviations from predefined specifications may occur.

3. Responsibilities

  • Production Personnel: Identify and report deviations promptly.
  • Production Chemist: Initiate immediate containment actions and notify QA.
  • Quality Assurance (QA): Investigate, evaluate, and document deviations and corrective actions.
See also  Gel Manufacturing: SOP for Ensuring Compliance with Cosmetic GMP Guidelines for Gels - V 2.0

4. Accountability

The Head – Manufacturing is accountable for ensuring timely identification, escalation, and resolution of deviations within the Gel Manufacturing Department.

5. Procedure

5.1 Identification of Deviations

  1. Monitor for any anomaly or non-conformance in process parameters, environmental controls, equipment functioning, material attributes, or documentation.
  2. Examples include: incorrect pH value, over/underweight filling, air entrapment, unexpected color change, equipment malfunction, etc.
  3. Immediately record the deviation in the Deviation Log (Annexure-1).

5.2 Initial Containment Actions

  1. Halt the process and isolate affected material or batch if critical deviation is observed.
  2. Label the material/batch as “Under Investigation.”
  3. Retain evidence or samples for QA evaluation.

5.3 Communication Protocol

  1. Inform the Production Chemist and QA Officer immediately upon detecting a deviation.
  2. QA shall log the deviation and classify it as minor or major.
  3. QA will determine whether immediate process resumption is permissible or if full investigation is needed.
See also  Gel Manufacturing: SOP for Setting Up Filling Machines for Gels - V 2.0

5.4 Immediate Corrective Actions

  • Adjust machine settings (e.g., fill volume, mixing speed, temperature) within approved ranges.
  • Replace or recalibrate faulty instruments if required.
  • Reprocess only after QA approval and batch impact assessment.
  • Restart operation only after QA line clearance is obtained.

5.5 Documentation and Follow-up

  1. Record all corrective actions in the Corrective Action Record (Annexure-2).
  2. QA to determine if CAPA (Corrective and Preventive Action) is required.
  3. Update Batch Manufacturing Record (BMR) with deviation summary and actions taken.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Deviation Log – Annexure-1
  2. Corrective Action Record – Annexure-2
See also  Gel Manufacturing: SOP for Cleaning of Equipment Post Gel Manufacturing - V 2.0

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • WHO TRS 986 Annex 2 – GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Deviation Log

Date Time Batch No. Description of Deviation Reported By Initial Action QA Remarks

Annexure-2: Corrective Action Record

Batch No.
Deviation ID
Corrective Action Taken
Person Responsible
Date of Action
QA Approval

Revision History

Revision Date Revision No. Change Description Reason Approved By
01/06/2022 1.0 Initial release New SOP QA Head
02/06/2025 2.0 Expanded procedure and updated annexures Process Improvement QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: API Manufacturing: SOP for Issuance and Control of Logbooks – V 2.0
Next Post: Analytical Method Development: Suitability Testing for Microbial Methods – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version